Flexion Therapeutics Liabilities 2024

Flexion Therapeutics Aktienanalyse

What does Flexion Therapeutics do?

Flexion Therapeutics is a biotechnology company specializing in the development and marketing of drugs for the treatment of pain and inflammation. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. Flexion Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Flexion Therapeutics's Liabilities

Flexion Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Flexion Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Flexion Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Flexion Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Flexion Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Flexion Therapeutics stock

What is the level of liabilities of Flexion Therapeutics this year?

Flexion Therapeutics has a debt balance of 0 USD this year.

What were the liabilities of Flexion Therapeutics compared to the previous year?

The liabilities of Flexion Therapeutics have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Flexion Therapeutics?

High liabilities can pose a risk for investors of Flexion Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Flexion Therapeutics?

Low liabilities mean that Flexion Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Flexion Therapeutics affect the company?

An increase in liabilities of Flexion Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Flexion Therapeutics affect the company?

A decrease in the liabilities of Flexion Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Flexion Therapeutics?

Some factors that can influence the liabilities of Flexion Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Flexion Therapeutics so important for investors?

The liabilities of Flexion Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Flexion Therapeutics take to modify the liabilities?

To change its liabilities, Flexion Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Flexion Therapeutics pay?

Over the past 12 months, Flexion Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Flexion Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Flexion Therapeutics?

The current dividend yield of Flexion Therapeutics is .

When does Flexion Therapeutics pay dividends?

Flexion Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Flexion Therapeutics?

Flexion Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Flexion Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Flexion Therapeutics located?

Flexion Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Flexion Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Flexion Therapeutics from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Flexion Therapeutics pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Flexion Therapeutics in the year 2023?

In the year 2023, Flexion Therapeutics distributed 0 USD as dividends.

In which currency does Flexion Therapeutics pay out the dividend?

The dividends of Flexion Therapeutics are distributed in USD.